Condition
Exocrine Pancreatic Insufficiency (EPI) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Exocrine Pancreatic Insufficiency (EPI) clinical trials that are recruiting, at sites in 9 countries (most in United States (3), Bulgaria (1), Hungary (1)). By phase: Phase 2 (2), Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 9Countries
Newest Exocrine Pancreatic Insufficiency (EPI) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Microbial pancreatic enzyme therapy versus porcine enzyme in chronic pancreatitis with exocrine pancreatic insufficiency | Phase 3 | Hyderabad, Telangana | Recruiting | Jul 13, 2026 |
| New lipase NHS7108 safety and potential efficacy in adults with exocrine pancreatic insufficiency | Phase 2 | Scottsdale, Arizona and 38 other locations | Recruiting | Apr 30, 2026 |
| Detecting pancreatic dysfunction in adults with type 2 diabetes | — | Aktobe, Aktobe | Recruiting | Apr 6, 2026 |
| ANG003 for pancreatic enzyme replacement in cystic fibrosis–related exocrine pancreatic insufficiency | Phase 2 | Long Beach, California and 27 other locations | Recruiting | Mar 4, 2026 |
| Evaluating RELiZORB for managing pancreatic enzyme insufficiency in tube-fed patients | Phase 3 | Boston, Massachusetts | Recruiting | Nov 18, 2024 |
All recruiting trials (5)
-
Microbial pancreatic enzyme therapy versus porcine enzyme in chronic pancreatitis with exocrine pancreatic insufficiency
This study tests whether a microbial (fungal) pancreatic enzyme product can work as well as the standard porcine enzyme in adults with chronic pancreatitis and PEI.
-
New lipase NHS7108 safety and potential efficacy in adults with exocrine pancreatic insufficiency
A 2-period study tests whether the new lipase NHS7108 works safely for adults with EPI by comparing it to the standard pancrelipase (Zenpep) at several doses over 14 days each.
-
Detecting pancreatic dysfunction in adults with type 2 diabetes
This project tests whether blood tests, a stool sample, and an ultrasound can identify pancreatogenic diabetes in adults with type 2 diabetes.
-
ANG003 for pancreatic enzyme replacement in cystic fibrosis–related exocrine pancreatic insufficiency
This trial will test whether ANG003, a new pancreatic enzyme replacement, works as well as Creon for people with cystic fibrosis who have exocrine pancreatic insufficiency.
-
Evaluating RELiZORB for managing pancreatic enzyme insufficiency in tube-fed patients
This study is testing if RELiZORB can help tube-fed patients with pancreatic enzyme insufficiency digest food better while they are in the hospital.
Related topics
Quick answers
How many Exocrine Pancreatic Insufficiency (EPI) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (3 trials), Bulgaria (1 trial), Hungary (1 trial), Italy (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.